> ## Content Index
> Fetch the complete content index at: https://www.coios.me/llms.txt
> Use this file to discover other available public pages before exploring further.

# Medicaid GLP-1 weight-management dispensing fell 85% after four states ended coverage
- URL: https://www.coios.me/medicaid-glp-1-weight-management-dispensing-fell-85-after/
- Published: 2026-11-18T13:18:37.000Z
- Updated: 2026-11-18T13:54:42.000Z
- Description: Weight-management GLP-1 prescriptions in four Medicaid programmes fell 85% in one quarter, with no rise in diabetes-labelled dispensing.
- Author: Daniel Ryan
- Tags: Data, models and systems, Health systems and access, Obesity, diabetes and GLP-1, United States, #preprint, #new, #item, #source-2026-11, #score-78

California, New Hampshire, Pennsylvania and South Carolina ended Medicaid weight-management GLP-1 coverage on 1 January 2026\. The authors used State Drug Utilization Data from 2024 Q1 to 2026 Q1, classifying products by FDA-approved indication. In the withdrawing states, prescriptions fell 85% between 2025 Q3 and 2026 Q1, from 1.06 to 0.16 per 100 enrollee-months. Six states that kept coverage went from 0.90 to 0.82 (difference-in-differences -0.67; 95% CI -1.21 to -0.18). GLP-1s labelled for other indications did not rise against 33 never-covering states (-0.03; 95% CI -0.29 to 0.23). The analysis covers only the first quarter after coverage ended.

*Why it is interesting: These four states held 60.5% of national Medicaid weight-management GLP-1 prescriptions before coverage ended. Within one quarter their dispensing fell 85%, and dispensing of diabetes-labelled products did not rise.*

Source

[medRxiv, 17 November 2026](https://doi.org/10.64898/2026.11.15.26368150?ref=coios.me)

Paper

Changes in Medicaid GLP-1 Prescription Dispensing After 4 States Ended Weight-Management Coverage

Authors

Lo W, Conti RM, Nguyen T, Gupta S, Wing C, Simon K

DOI

10.64898/2026.11.15.26368150

Type

Preprint

Design

Difference-in-differences of state drug utilisation data, 2024 Q1–2026 Q1, 4 withdrawing vs 6 continuing and 33 never-covering states; 1.09m weight-management prescriptions in 2025 Q4

Verdict

New finding

Driver

[Health systems and access](https://www.coios.me/d-health-systems/)

Driver

[Obesity, diabetes and GLP-1](https://www.coios.me/d-obesity-diabetes/)